DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Weber J, Mandala M, Del Vecchio M. et al.
Adjuvant Nivolumab vs. Ipilimumab in Resected Stage III or IV Melanoma.
N Engl J Med 2017;
377: 1824-1835
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.